Browsing Tag
NXP100
2 posts
Nuvectis Pharma just raised $100 million, so why are NVCT shareholders selling?
Nuvectis Pharma shares fell 19% after a $100 million offering priced at $20. Read what dilution, runway and pipeline expansion mean for NVCT investors now!
Nuvectis (NVCT) licenses two Haisco drugs as $1.46bn deal transforms its pipeline
Nuvectis licenses two Haisco drugs in a deal worth up to $1.46 billion. Find out how financing risk could reshape NVCT’s pipeline and investor outlook next.